From The Economic Times
Center-Right Owned by Bennett, Coleman & Co.Biocon CEO forecasts H2 results to outperform H1; company posts 52% fall in Q2 net profit; revenue up 2%
What's behind this
Biocon's net profit for the second quarter fell 57.3% to ₹56.7 crore. In the same quarter, total income rose to ₹4,423.4 crore, while total expenses increased to ₹4,361.9 crore.
AI-generated overview from 2 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
right · 2 outlets
Biocon reported a 52% drop in second-quarter net profit due to shipment delays caused by geopolitical issues. The company expects revenue growth in the second half of fiscal 2027 from its biosimilars and insulin demand. Launches of pertuzumab in Europe and Brazil are anticipated soon, contributing…
RSS excerpt
Biocon reported a 52% drop in second-quarter net profit due to shipment delays caused by geopolitical issues. The company expects revenue growth in the second half of fiscal 2027 from its biosimilars and insulin demand. Launches of pertuzumab in Europe and Brazil are anticipated soon, contributing…
